Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4-(2-amino-1,3-thiazol-4-yl)phenol is a phenolic thiazole derivative with the molecular formula C9H8N2OS. It is primarily recognized as a versatile chemical compound and building block in pharmaceutical research, utilized for the synthesis of various drug compounds. Studies have indicated its potential therapeutic properties, including antioxidant and antibacterial activities. As an antioxidant agent, it shows promise in combating oxidative stress, which is implicated in numerous diseases. Its antibacterial applications stem from its potential to inhibit bacterial growth, suggesting its utility in the development of new antimicrobial agents. The compound is also being investigated as a potential therapeutic agent for the treatment of certain medical conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 4-(2-amino-1,3-thiazol-4-yl)phenol.